Neogen Corp. (NG2)
XSTU
Real-time Data
06:00 AM
Day's Range
10.1352 wk Range
4.68Overview - NG2 - Neogen Corp.
Key Statistics
Valuation
P/E (Trailing)
‪-300.00‬
PEG Ratio
‪3.05‬
Price / Book
‪1.24‬
Profitability
Gross Margin
‪47.84%‬
Profit Margin
‪46.93%‬
Operating Margin
‪5.58%‬
Return on Assets
‪-0.23%‬
Return on Equity
‪-0.37%‬
Ownership
Shares Outstanding
217.70M
Price stats
50-Day Avg
‪10.05‬
200-Day Avg
‪8.52‬
Peers - NG2 - Neogen Corp.
Peer Comparison
Compared with companies in Medical Devices listed on XSTU.
- NG2XSTUNeogen Corp.+60.50%52-week change-300.00P/E (Trailing)‪46.93%‬Profit Margin
- PENXSTUPBF Energy Inc.+68.22%52-week change7.71P/E (Trailing)‪3.93%‬Profit Margin
- HQE1XSTUCytoSorbents Corporation+94.73%52-week change-2.28P/E (Trailing)‪71.47%‬Profit Margin
- LT3XSTUAxogen, Inc.+61.76%52-week change-111.53P/E (Trailing)‪74.31%‬Profit Margin
- 51KBXSTUAVITA Medical, Inc.+55.59%52-week change-6.12P/E (Trailing)‪82.13%‬Profit Margin
- HAZXSTUHaemonetics Corporation+53.04%52-week change44.61P/E (Trailing)‪59.03%‬Profit Margin
- 6GJXSTUGlaukos Corp.+49.26%52-week change-41.16P/E (Trailing)‪55.72%‬Profit Margin
Profile Summary - NG2 - Neogen Corp.
About
Neogen Corp. is a food and animal safety company that develops, manufactures, and markets diagnostic and testing solutions for regulated industries. Its Food Safety segment provides test kits, culture media, and related products used by food and feed producers, processors, laboratories, and regulators to detect…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
